Inventor

David M. Armistead

Inventor

Maynard, MA, US

Overview

1994–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 33 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%

C07DHeterocyclic compounds21%

A61KPreparations for medical, dental or toiletry purposes14%

C07CAcyclic or carbocyclic compounds9%

C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms6%

G01NInvestigating or analysing materials by determining their chemical or physical properties6%

C07KPeptides5%

C12NMicroorganisms or enzymes5%

C12YEnzymes3%

C40BCombinatorial chemistry3%

PatentTitleYear

10,989,710Identifying new therapeutic agents2021 10,203,323Identifying new therapeutic agents2019 9,796,718'6-(benzo[d]thiazol-5-yl)-n-(3,4-dimethoxyphenyl)imidazo[1,2-a]pyrazin-8-amine'2017 9,428,845'Identifying new therapeutic agents'2016 8,748,607'Imidazopyrizine syk inhibitors'2014 8,455,493'Imidazopyrazine Syk inhibitors'2013 7,527,952'Crystals of inosine monophosphate dehydrogenase/oxidized inosine monophosphate thiomidate intermediate/mycophenolic acid (IIMPDH/XMP*/MPA)'2009 7,329,681'Inhibitors of IMPDH enzyme'2008 7,282,504'Kinase inhibitors'2007 7,216,041'Methods of using the structure coordinates of molecules comprising an IMPDH-like binding pocket'2007 7,074,789'Kinase inhibitors'2006 7,065,452'Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them'2006 6,967,214'Inhibitors of IMPDH enzyme'2005 6,541,496'Inhibitors of IMPDH enzyme'2003 6,518,291'Inhibitors of IMPDH enzyme'2003 6,495,558'Kinase inhibitors'2002 6,344,465'Inhibitors of IMPDH enzyme'2002 6,326,387'Methods and compositions for stimulating neurite growth'2001 6,128,582'Molecules comprising an IMPDH-like binding pocket and encoded data storage medium capable of graphically displaying them'2000 6,124,328'Methods and compositions for stimulating neurite growth'2000 6,054,472'Inhibitors of IMPDH enzyme'2000 6,037,370'Methods and compositions for stimulating neurite growth'2000 5,978,740'Molecules comprising a calcineurin-like binding pocket and encoded data storage medium capable of graphically displaying them'1999 5,935,954'Compounds with improved multi-drug resistance activity'1999 5,932,600'Inhibitors of IMPDH enzyme'1999 5,807,876'Inhibitors of IMPDH enzyme'1998 5,723,459'Biologically active acylated amino acid derivatives'1998 5,717,092'Compounds with improved multi-drug resistance activity'1998 5,665,774'Immunosuppressive compounds'1997 5,654,332'Methods and compositions for stimulating neurite growth'1997 5,620,971'Biologically active acylated amino acid derivatives'1997 5,516,797'Immunosuppressive compounds'1996 5,330,993'Immunosuppressive compounds'1994

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1994–2009Patents assigned to VERTEX PHARMA (22)· patent assignee history

1994–2008Based in Maynard, MA, US· patent location history

2002–2007Patents assigned to AMGEN INC (3)· patent assignee history

2002–2021Based in Sudbury, MA, US· patent location history

2013–2017Patents assigned to GILEAD CONNECTICUT INC (3)· patent assignee history

2013–2016Patents assigned to ARMISTEAD DAVID M (2)· patent assignee history

2016–2019Patents assigned to WARP DRIVE BIO INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
VERTEX PHARMA	22	1994–2009
AMGEN INC	3	2002–2007
GILEAD CONNECTICUT INC	3	2013–2017
ARMISTEAD DAVID Mself	2	2013–2016
WARP DRIVE BIO INC	2	2016–2019

Locations

Location	Patents	Span
Maynard, Massachusetts, US	21	1994–2008
Sudbury, Massachusetts, US	12	2002–2021